Iris-Melanie Noebauer-Huhmann,Filip M. Vanhoenacker,Joan C. Vilanova,Alberto S. Tagliafico,Marc-André Weber,Radhesh K. Lalam,Thomas Grieser,Violeta Vasilevska Nikodinovska,Jacky W. J. de Rooy,Olympia Papakonstantinou,Catherine Mccarthy,Luca Maria Sconfienza,Koenraad Verstraete,José Martel-Villagrán,Pavol Szomolanyi,Frédéric E. Lecouvet,Diana Afonso,Omar M. Albtoush,Giacomo Aringhieri,Remide Arkun,Gunnar Aström,Alberto Bazzocchi,Rajesh Botchu,Martin Breitenseher,Snehansh Chaudhary,Danoob Dalili,Mark Davies,Milko C. de Jonge,Berna D. Mete,Jan Fritz,Jan L. M. A. Gielen,Geoff Hide,Amanda Isaac,Slavcho Ivanoski,Ramy M. Mansour,Lorenzo Muntaner-Gimbernat,Ana Navas,Paul O´Donnell,Şebnem Örgüç,Winston Rennie,Santiago Resano,Philip Robinson,Hatice T. Sanal,Simone A. J. Ter Horst,Kirsten van Langevelde,Klaus Wörtler,Marita Koelz,Joannis Panotopoulos,Reinhard Windhager,Johannes L. Bloem

Abstract:Abstract Objectives Early, accurate diagnosis is crucial for the prognosis of patients with soft tissue sarcomas. To this end, standardization of imaging algorithms, technical requirements, and reporting is therefore a prerequisite. Since the first European Society of Musculoskeletal Radiology (ESSR) consensus in 2015, technical achievements, further insights into specific entities, and the revised WHO-classification (2020) and AJCC staging system (2017) made an update necessary. The guidelines are intended to support radiologists in their decision-making and contribute to interdisciplinary tumor board discussions. Materials and methods A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries. Statements were scored online by level of agreement (0 to 10) during two iterative rounds. Either “group consensus,” “group agreement,” or “lack of agreement” was achieved. Results Eight sections were defined that finally contained 145 statements with comments. Overall, group consensus was reached in 95.9%, and group agreement in 4.1%. This communication contains the first part consisting of the imaging algorithm for suspected soft tissue tumors, methods for local imaging, and the role of tumor centers. Conclusion Ultrasound represents the initial triage imaging modality for accessible and small tumors. MRI is the modality of choice for the characterization and local staging of most soft tissue tumors. CT is indicated in special situations. In suspicious or likely malignant tumors, a specialist tumor center should be contacted for referral or teleradiologic second opinion. This should be done before performing a biopsy, without exception. Clinical relevance The updated ESSR soft tissue tumor imaging guidelines aim to provide best practice expert consensus for standardized imaging, to support radiologists in their decision-making, and to improve examination comparability both in individual patients and in future studies on individualized strategies. Key Points • Ultrasound remains the best initial triage imaging modality for accessible and small suspected soft tissue tumors. • MRI is the modality of choice for the characterization and local staging of soft tissue tumors in most cases; CT is indicated in special situations. Suspicious or likely malignant tumors should undergo biopsy. • In patients with large, indeterminate or suspicious tumors, a tumor reference center should be contacted for referral or teleradiologic second opinion; this must be done before a biopsy.

[Innovations in the classification of soft tissue tumors]

Classification of Soft Tissue Lesions and General Principles of Soft Tissue Pathology

Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update

[Pathology of soft tissue sarcomas]

What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition

Updates on WHO classification for small round cell tumors: Ewing Sarcoma vs. Everything Else

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors

Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours

WHO classification of tumours of soft tissue and bone

New entities, concepts, and questions in childhood tumor pathology

Update of pediatric soft tissue tumors with review of conventional MRI appearance—part 2: vascular lesions, fibrohistiocytic tumors, muscle tumors, peripheral nerve sheath tumors, tumors of uncertain differentiation, and undifferentiated small round cell sarcomas

The 2023 WHO updates on skin tumors: advances since the 2018 edition

Update of pediatric soft tissue tumors with review of conventional MRI appearance—part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors

Soft tissue sarcomas: From a morphological to a molecular biological approach

Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)

Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry

The current landscape of rhabdomyosarcomas: an update

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

[Pediatric soft tissue tumors : Tumors of uncertain origin]

PET/CT and PET/MR in Soft Tissue Sarcoma: An Update

World health organization classification of bone tumors (fifth edition): What a radiologist needs to know?